Position
Fidelity in Mineralys Therapeutics, Inc.
Back to the book · All holders of MLYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$496.3K$27.09 → $26.98
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 5.06M | $183.5M | — | — | — | 0.0% |
| Q1 2026 | 4.86M | $131.7M | $27.09 | −$44.7M | −$7.13M | 0.0% |
| Q2 2026 | 4.51M | $121.7M | $26.98 | −$496.3K | −$9.47M | 0.0% |